Examination of the effect of renal protection of aliskiren in chronic renal failure patient with hypertension (preservation period).
Phase of Trial: Phase III
Latest Information Update: 13 May 2016
At a glance
- Drugs Aliskiren (Primary)
- Indications Hypertension
- Focus Pharmacodynamics; Registrational
- Acronyms ERA-CRF HT
- 10 Sep 2015 Status changed from recruiting to completed, as reported by University Hospital Medical Information Network - Japan.
- 26 Mar 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
- 06 Oct 2009 New trial record